Skip to main content
          Skip to FDA Search
          Skip to in this section menu
          Skip to footer links


U.S. flagAn official website of the United States government

					Here’s how you know
          			Dot gov**The .gov means it’s official.**Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
							      SSL**The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. 
			U.S. Food and Drug Administration
				
        Search
            Menu
							
						Search FDA
									
									Submit search 
		Featured
							Contact FDA
	                FDA Guidance Documents
	                Recalls, Market Withdrawals and Safety Alerts
	                Press Announcements
	                Warning Letters
	                Advisory Committees
	                En Español

					Products
            Food
							Drugs
							Medical Devices
							Radiation-Emitting Products
							Vaccines, Blood, and Biologics
							Animal and Veterinary
							Cosmetics
							Tobacco ProductsTopics
            About FDA
							Combination Products
							Regulatory Information
							Safety
							Emergency Preparedness
							International Programs
							News and Events
							Training and Continuing Education
							Inspections and Compliance
							Science and ResearchInformation For
            Consumers
	            Patients
	            Industry
	            Health Professionals
	            Federal, State and Local Officials 
 In this section:

                Regulation of the Blood Supply

Regulation of the Blood Supply

                        Exceptions and Alternative Procedures Approved Under 21 CFR 640.120
          Review Checklist Home
          Vaccines, Blood & Biologics
          Blood & Blood Products
          Regulation of the Blood Supply
          Exceptions and Alternative Procedures Approved Under 21 CFR 640.120Regulation of the Blood Supply Exceptions and Alternative Procedures Approved Under 21 CFR 640.120
  
  	
    Subscribe to Email Updates
    Share
    Post
    Linkedin

    Email
    PrintUnder title 21 of the Code of Federal Regulations 640.120 (a), the Director, Center for Biologics Evaluation and Research, may issue an exception or alternative  to any requirement in subchapter F (Biologics, Parts 600-680) of Chapter I (Food and Drug Administration, Department of Health and Human Services) of title 21 of the Code of Federal Regulations regarding blood, blood components or blood products.

Both licensed and unlicensed blood establishments must submit requests for an exception or alternative to the requirements in Parts 600-680. Licensed establishments must submit the request in accordance with 21 CFR 601.12 and may reference our guidance document entitled: Changes to an Approved Application: Biological Products: Human Blood and Blood Components Intended for Transfusion or for Further Manufacture (December 2014).

Requests for such exceptions or alternative procedures should be made in writing; however, if there are difficult circumstances and submission of a written request is not feasible, such requests may be made orally, followed by a written request within 5 working days. If the Director issues an exception or alternative orally, the Director will follow up with a written notice.

It should be noted that requests for exceptions or alternatives to the regulations include specific circumstances and may require submission of supporting data unique to the circumstance. Publication of this list does not necessarily mean that the exceptions or alternatives can be generally applied to other manufacturers.

Related Information

Exceptions and Alternative Procedures Approved Under 21 CFR 640.120 (a).(pdf)

                                                                                  Content current as of:
      05/12/2023
              
              
Regulated Product(s)
		 Biologics
			  			     			  						              
			
			 
			  Blood ProductsRegulation of the Blood Supply

          
                        Exceptions and Alternative Procedures Approved Under 21 CFR 640.120
          Review Checklist
 Subscribe for CBER Updates
                        Get e-mail updates on What’s New at CBER!
    Enter your email address to subscribe:
 Footer Links
    FDA Archive
          About FDA
          Accessibility
      Visitor Information
          Website Policies / Privacy
          No FEAR Act
          Vulnerability Disclosure Policy
      FOIA
          HHS.gov
          USA.gov
    Contact FDA
      Follow FDA on Facebook
      Follow FDA on X
      Follow FDA on Instagram
      Follow FDA on LinkedIn
      View FDA videos on YouTube
      Subscribe to FDA RSS feeds
    FDA Homepage
    Contact Number
      1-888-INFO-FDA (1-888-463-6332) Back toTop